Identification of polysaccharide capsules among extensively drug-resistant genitourinary Haemophilus parainfluenzae isolates.
Adult
Anti-Bacterial Agents
/ pharmacology
Chloramphenicol
/ pharmacology
Drug Resistance, Multiple, Bacterial
Female
Haemophilus Infections
/ microbiology
Haemophilus parainfluenzae
/ classification
Humans
Macrolides
/ pharmacology
Male
Microbial Sensitivity Tests
Operon
Phylogeny
Polysaccharides, Bacterial
/ genetics
Quinolones
/ pharmacology
Tetracycline
/ pharmacology
Whole Genome Sequencing
/ methods
beta-Lactams
/ pharmacology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 03 2019
14 03 2019
Historique:
received:
05
10
2018
accepted:
21
02
2019
entrez:
16
3
2019
pubmed:
16
3
2019
medline:
2
10
2020
Statut:
epublish
Résumé
The human commensal Haemophilus parainfluenzae is emerging as an opportunistic multidrug-resistant pathogen. The objectives of this work were to characterise a new capsular operon of extensively drug-resistant (XDR) H. parainfluenzae clinical isolates and study their resistance mechanisms using whole-genome sequencing. All strains were resistant to: ß-lactams, via amino acid changes in PBP3 (S385T, I442F, V511A, N526K and V562I); quinolones, by alterations in GyrA (S84F and D88Y) and ParC (S84F and S138T); chloramphenicol, through the presence of catS; macrolides, via the presence of mel and mef(E)-carrying MEGA element; and tetracycline, through the presence of tet(M) and/or tet(B). Phylogenetic analysis revealed high genomic diversity when compared to the H. parainfluenzae genomes available on the NCBI, the isolates from this study being closely related to the Swiss XDR AE-2096513. A full capsular operon showing homology to that of H. influenzae was identified, in accordance with the observation of a capsular structure by TEM. This study describes for the first time a capsular operon in H. parainfluenzae, a major determinant of pathogenicity that may contribute to increased virulence in XDR clinical isolates. Moreover, phylogenetic analysis suggests the possible spread of an XDR-encapsulated strain in Europe.
Identifiants
pubmed: 30872664
doi: 10.1038/s41598-019-40812-2
pii: 10.1038/s41598-019-40812-2
pmc: PMC6418240
doi:
Substances chimiques
Anti-Bacterial Agents
0
Macrolides
0
Polysaccharides, Bacterial
0
Quinolones
0
beta-Lactams
0
Chloramphenicol
66974FR9Q1
Tetracycline
F8VB5M810T
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4481Références
Antimicrob Agents Chemother. 2003 Mar;47(3):1017-22
pubmed: 12604536
Infect Immun. 2005 Aug;73(8):4653-67
pubmed: 16040978
Antimicrob Agents Chemother. 2009 Feb;53(2):343-53
pubmed: 19001115
Antimicrob Agents Chemother. 1996 Jul;40(7):1741-4
pubmed: 8807076
Can J Infect Dis Med Microbiol. 2010 Spring;21(1):e20-2
pubmed: 21358875
Antimicrob Agents Chemother. 2013 Jun;57(6):2867-9
pubmed: 23545526
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Pediatr Nephrol. 2007 Sep;22(9):1321-5
pubmed: 17541792
BMC Microbiol. 2008 Feb 25;8:35
pubmed: 18298818
J Med Microbiol. 2015 Jul;64(7):724-730
pubmed: 25976004
Can J Infect Dis Med Microbiol. 2016;2016:4503025
pubmed: 27516778
Clin Microbiol Infect. 2003 Jun;9(6):467-74
pubmed: 12848721
Clin Rheumatol. 2015 Apr;34(4):811-4
pubmed: 24584486
Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Antimicrob Agents Chemother. 2014;58(1):212-20
pubmed: 24145532
J Antimicrob Chemother. 2013 May;68(5):1054-9
pubmed: 23335113
Tex Heart Inst J. 2013;40(5):608-11
pubmed: 24391338
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Sex Transm Infect. 2016 Feb;92(1):29-31
pubmed: 26139207
Infect Genet Evol. 2016 Oct;44:507-509
pubmed: 27497656
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Microb Drug Resist. 2017 Sep;23(6):667-673
pubmed: 28103180
Genome Biol. 2014;15(11):524
pubmed: 25410596
J Antimicrob Chemother. 2008 Mar;61(3):509-14
pubmed: 18245789
J Antimicrob Chemother. 2011 Mar;66(3):673-5
pubmed: 21127039
Antimicrob Agents Chemother. 1996 Sep;40(9):2131-6
pubmed: 8878594
Infect Immun. 2003 Jun;71(6):3639-44
pubmed: 12761153
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
BMC Microbiol. 2016 Apr 06;16:62
pubmed: 27052615
J Microbiol Immunol Infect. 2015 Aug;48(4):450-2
pubmed: 23357607
Int J Antimicrob Agents. 2017 Feb;49(2):265-266
pubmed: 27986332
Clin Microbiol Rev. 2014 Apr;27(2):214-40
pubmed: 24696434
New Microbiol. 2009 Apr;32(2):213-5
pubmed: 19579703